In contrast, the inhibition of CREB1 or TXNIP, especially in combination with proteasome inhibitors, is extremely toxic to MM cells due to increased ROS-mediated autophagy and terminal apoptotic UPR (Fig. 5L). Here, CREB1 is linked to Miyoshi myopathy.